HbA1c Testing Devices Market to Grow with a CAGR of 6.45% through 2029
Increase in the incidence of vitamin deficiencies and increase in the
aging population is expected to drive the Global HbA1c Testing Devices Market
growth in the forecast period, 2025-2029
According to TechSci Research report, “HbA1c
Testing Devices Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2029F”, the Global HbA1c Testing Devices
Market stood at USD 1.98 billion in 2023 and is anticipated to grow with a CAGR
of 6.45% in the forecast period through 2029.
Increasing awareness among healthcare professionals
and patients regarding the critical role of regular HbA1c monitoring in
managing diabetes is a significant driver for market growth. Educational
initiatives, clinical guidelines, and advocacy campaigns highlight the benefits
of maintaining optimal blood sugar levels to prevent complications. Healthcare
providers are increasingly integrating HbA1c testing into comprehensive
diabetes care plans, boosting demand for testing devices. Enhanced patient
education empowers individuals to take an active role in their health
management, driving higher adoption of HbA1c testing devices and expanding the
market.
Also, prioritizing early diagnosis and proactive
disease management is central to global healthcare strategies. HbA1c testing
devices enable accurate and efficient monitoring of long-term glycemic control,
facilitating timely interventions such as lifestyle adjustments and
medications.
Early detection of elevated HbA1c levels supports
efforts to prevent diabetes complications, thereby enhancing patient outcomes.
This emphasis on preventive healthcare and targeted disease management
strategies by healthcare systems fuels the adoption of HbA1c testing devices,
propelling market growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global HbA1c Testing Devices Market”
The Global HbA1c Testing Devices Market is segmented
into type of device, technology, end user, regional distribution, and company.
Based on end user, the Hospitals & Clinics segment has
emerged as the predominant market leader, Hospitals & Clinics are major users of HbA1c
testing devices due to their comprehensive healthcare services and diagnostic
capabilities. In hospital settings, HbA1c testing is crucial for managing
diabetes among admitted patients across various departments, including
endocrinology, internal medicine, and pediatrics. Hospitals often require a
wide range of diagnostic tools to support diverse patient populations with
varying healthcare needs, making HbA1c testing devices integral to routine
clinical practice. Hospitals typically handle large volumes of patient visits
and diagnostic testing procedures daily. Given the high prevalence of diabetes
globally, hospitals perform numerous HbA1c tests to monitor and manage glycemic
control among diabetic patients. The ability of HbA1c testing devices to
provide accurate and reliable measurements over time supports healthcare
providers in making informed decisions regarding patient care, treatment
adjustments, and long-term management strategies. HbA1c testing devices used in
hospitals are often integrated with hospital information systems (HIS) or
laboratory information systems (LIS). This integration facilitates seamless
data management, electronic recordkeeping, and accessibility of test results
across healthcare departments. Healthcare providers can retrieve patient data
efficiently, track disease progression, and coordinate multidisciplinary care
efforts. Integration with digital health platforms enhances workflow
efficiency, reduces administrative burden, and supports evidence-based clinical
decision-making in hospital settings.
The Europe region is experiencing rapid market growth.
Europe has been experiencing an increasing prevalence of diabetes, both type 1
and type 2, driven by factors such as aging populations, sedentary lifestyles,
and unhealthy dietary habits. According to the International Diabetes
Federation (IDF), Europe has one of the highest prevalence rates of diabetes
globally. This demographic trend necessitates robust diabetes management
strategies, including routine HbA1c testing, to monitor and control blood
glucose levels effectively. European countries prioritize healthcare policies
aimed at improving chronic disease management, including diabetes. National
health systems in countries like Germany, France, and the United Kingdom
emphasize early diagnosis, preventive care, and evidence-based treatment
guidelines for diabetes. Government-funded healthcare initiatives and
reimbursement policies support the adoption of advanced medical technologies,
including HbA1c testing devices, across healthcare facilities and clinical
settings. Europe boasts a well-developed healthcare infrastructure
characterized by advanced medical facilities, research institutions, and
academic centers specializing in diabetes care and clinical research. The
region's healthcare sector benefits from continuous investments in medical
innovation, research, and development, fostering technological advancements in
diagnostic technologies such as HbA1c testing devices. These advancements
enhance diagnostic accuracy, streamline healthcare workflows, and improve patient
outcomes.
Major companies operating in Global HbA1c Testing
Devices Market are:
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories Inc.
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Human Inc.
- Trinity Biotech Plc.
- A. Menarini Diagnostics s.r.l
- SAKAE CO. LTD.
- SEKISUI MEDICAL CO., LTD
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“Global HbA1c Testing Devices Market exhibits robust
growth prospects driven by increasing diabetes prevalence worldwide,
technological advancements enhancing device capabilities, and strategic
healthcare initiatives promoting early diagnosis and personalized disease
management. Stakeholders navigating this dynamic market landscape are poised to
capitalize on opportunities by leveraging innovation, regulatory compliance,
and strategic partnerships to meet evolving healthcare demands and improve
patient outcomes globally”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“HbA1c Testing Devices Market – Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Type of Device (Laboratory-based Testing Devices, Point-of-care (POC) Testing Devices), By Technology (Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High-Performance Liquid Chromatography, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Homecare Settings), By Region, Competition, 2019-2029F”, has evaluated
the future growth potential of Global HbA1c Testing Devices Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global HbA1c Testing Devices Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com